Generics Shares of London-listed generics drugmaker Hikma Pharmaceuticals rose 1.5% to 2,553 pence on Friday, after the Jordanian company announced that its wholly-owned US subsidiary has received approval from the US Food and Drug Administration for its icosapent ethyl capsules, 1gm, the generic equivalent to Vascepa, a fish-oil-based drug from US firm Amarin. 25 May 2020